Burden and Prevention of Adverse Cardiac Events in Patients with Concomitant Chronic Heart Failure and Coronary Artery Disease: A Literature Review

por Lavoie, Louis, Khoury, Hanane, Welner, Sharon, Briere, Jean‐Baptiste
Publicado 2016

Ivabradine in patients with heart failure: a systematic literature review

por Khan, Zeba M., Briere, Jean Baptiste, Olewinska, Elzbieta, Khrouf, Fatma, Nikodem, Mateusz
Publicado 2023

Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review

por Bauersachs, Rupert, Zeymer, Uwe, Brière, Jean-Baptiste, Marre, Caroline, Bowrin, Kevin, Huelsebeck, Maria
Publicado 2019

Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland

por Soini, Erkki, Virtanen, Outi, Väätäinen, Saku, Briere, Jean-Baptiste, Bowrin, Kevin, Millier, Aurelie
Publicado 2020

Real-world cost-effectiveness of rivaroxaban and apixaban vs VKA in stroke prevention in non-valvular atrial fibrillation in the UK

por Bowrin, Kevin, Briere, Jean-Baptiste, Levy, Pierre, Millier, Aurélie, Tardu, Jean, Toumi, Mondher
Publicado 2020

Antithrombotic treatment patterns in patients with atrial fibrillation in Italy pre- and post-DOACs: the REPAIR study

por Esposti, Luca D, Briere, Jean-Baptiste, Bowrin, Kevin, Diego, Sangiorgi, Perrone, Valentina, Pasquale, Giuseppe Di
Publicado 2019

Burden of comorbidities among Japanese patients with atrial fibrillation: a case study of dyspepsia

por Kinoshita, Yoshikazu, DiBonaventura, Marco, Rossi, Bruno, Iwamoto, Kazuya, Wang, Edward C Y, Briere, Jean-Baptiste
Publicado 2013

Estimation of the costs attributable to vitamin K antagonist treatment in patients with non-valvular atrial fibrillation from a French societal perspective

por Levy, Pierre, Smadja, David, Dorey, Julie, Toumi, Mondher, Meinecke, Anna-Katharina, Bowrin, Kevin, Briere, Jean-Baptiste
Publicado 2019

Real-world cost-effectiveness of rivaroxaban compared with vitamin K antagonists in the context of stroke prevention in atrial fibrillation in France

por Bowrin, Kevin, Briere, Jean-Baptiste, Fauchier, Laurent, Coleman, Craig, Millier, Aurélie, Toumi, Mondher, Clay, Emilie, Levy, Pierre
Publicado 2020

Assessment of the burden of disease for patients with peripheral artery disease undergoing revascularization in England

por Portas, Laura, Bauersachs, Rupert, Bowrin, Kevin, Briere, Jean-Baptiste, Cohen, Alexander, Huelsebeck, Maria, Jones, Schuyler, Quint, Jennifer K
Publicado 2022

Antithrombotic Treatments in Patients with Chronic Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomised Controlled Trials

por Bauersachs, Rupert, Wu, Olivia, Briere, Jean-Baptiste, Bowrin, Kevin, Borkowska, Katarzyna, Jakubowska, Anna, Taieb, Vanessa, Toumi, Mondher, Huelsebeck, Maria
Publicado 2020

Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibril...

por Coleman, Craig I., Briere, Jean-Baptiste, Fauchier, Laurent, Levy, Pierre, Bowrin, Kevin, Toumi, Mondher, Millier, Aurélie, Taieb, Vanessa, Wu, Olivia
Publicado 2019

Health economic evaluation of rivaroxaban in the treatment of patients with chronic coronary artery disease or peripheral artery disease

por Cowie, Martin R, Lamy, André, Levy, Pierre, Mealing, Stuart, Millier, Aurélie, Mernagh, Paul, Cristeau, Olivier, Bowrin, Kevin, Briere, Jean-Baptiste
Publicado 2020

Cost-effectiveness Analysis of Rivaroxaban in the Secondary Prevention of Acute Coronary Syndromes in Sweden

por Begum, Najida, Stephens, Stephanie, Schoeman, Olaf, Fraschke, Anina, Kirsch, Bodo, Briere, Jean-Baptiste, Verheugt, Freek W. A., van Hout, Ben A.
Publicado 2015

Real-world cost-effectiveness analysis of NOACs versus VKA for stroke prevention in Spain

por Escobar Cervantes, Carlos, Martí-Almor, Julio, Cabeza, Alejandro Isidoro Pérez, Bowrin, Kevin, Llorac Moix, Aleix, Genís Gironès, Mar, Gasche, David, Millier, Aurélie, Tardu, Jean, Toumi, Mondher, Briere, Jean-Baptiste
Publicado 2022